About this role
About Myriad Genetics Myriad Genetics is a global leader in molecular diagnostics, dedicated to advancing precision medicine and improving patient outcomes. Our innovative solutions empower clinicians with actionable insights to guide cancer care. In 2026, we will introduce our Precise Minimal Residual Disease (MRD) testing solution—a breakthrough in cancer monitoring and recurrence detection. Combined with our industry-leading hereditary cancer and tumor profiling tests, Myriad offers a comprehensive oncology portfolio that helps clinicians make confident, data-driven decisions.